Literature DB >> 21507295

[Effects of TNF-α on ICAM-1 and LFA-1 expression in peripheral blood mononuclear cells of children with febrile seizures].

Dan Sun1, Zhi-Sheng Liu, Hui Yao, Shi-Xiu Kang, Cai-Ying He, Jia-Sheng Hu, Ge-Fei Wu, Fang-Lin Wang.   

Abstract

OBJECTIVE: To study the effects of TNF-α on ICAM-1 and LFA-1 expression in peripheral blood mononuclear cells (PBMC) of children with febrile seizures (FS).
METHODS: Sixteen children with FS and 16 age- and gender-matched healthy children were enrolled. The samples of PBMC from FS children were randomized into two groups with or without TNF-α treatment (TNF-α concentration 1.0 ng/mL). PBMC were purified and cultured with a conventional method in vitro. The expression of ICAM-1 and LFA-1 in PBMC was determined by flow cytometry (FCM).
RESULTS: ICAM-1[(20±9)% vs (14±7)%)]and LFA-1[(43±16)% vs (30±16)%]expression in PBMC in the untreated FS group was significantly higher than that in the normal control group (P<0.05). Compared with the untreated FS group, the treatment with TNF-α remarkably increased the ICAM-1 expression[(27±11)%](P<0.05). PBMC LFA-1 expression[(52±21)%]in the TNF-α-treated group was higher than that in the untreated FS group, although there were no statistical differences between the two groups.
CONCLUSIONS: TNF-α treatment may increase LFA-1 and ICAM-1 expression in PBMC of children with FS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507295

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  2 in total

1.  Up-regulation of ICAM-1mRNA and IL-1βmRNA in lung tissues of a rat model of COPD.

Authors:  Mingli Ji; Yuxia Wang; Xiaopeng Li; Zhibin Qian
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Repression of GSK3 restores NK cell cytotoxicity in AML patients.

Authors:  Reshmi Parameswaran; Parameswaran Ramakrishnan; Stephen A Moreton; Zhiqiang Xia; Yongchun Hou; Dean A Lee; Kalpana Gupta; Marcos deLima; Rose C Beck; David N Wald
Journal:  Nat Commun       Date:  2016-04-04       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.